Tetracyclines (TetraC) are widely used in dermatology for both inflammatory and infectious
dermatoses; recently both in vivo and in vitro studies started to suggest also a potential …

Currently, there is a race against time to identify prophylactic and therapeutic treatments
against COVID-19. Until these treatments are developed, tested, and mass produced, it …

Dear Editor There are differing opinions on use of biologic drugs for psoriasis during the
COVID-19 outbreak. 1-3 We would like to share our experience at the biggest hospital in our …

In their work, Conforti et al urge experts to broadly investigate the combination of
doxycycline and hydroxychloroquine in treating coronavirus disease (COVID-19). 1 The …

Tetracyclines exhibit anti-viral, anti-inflammatory, and immunomodulatory activities via
various mechanisms. The present study investigated the efficacy and safety of …

Dear Editor, We read with interest the paper by Conforti et al entitled “COVID-19 and
psoriasis: is it time to limit treatment with immunosuppressants? A call for action.” 1 In their …

Coronavirus disease 2019 (COVID-19) is a global infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Approximately 15% of severe …

The aim of this study was to evaluate the changing trends in dermatology clinical practice at
a tertiary center during the coronavirus disease 2019 (COVID‐19) pandemic. This …

Dear Editor, The recent SARS-CoV-2 pandemic, for which there is still no approved vaccine,
required research into effective treatments to limit, contain, and improve the outcome of …

The coronavirus disease 2019 (COVID-19) pandemic has prompted questions regarding the
use of biologics in patients with inflammatory skin conditions. Infection with COVID-19 incites …